Mankind Pharma Closes Trading Window for Q1 FY27 Results

Mankind Pharma Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from July 01, 2026, and will remain in effect until 48 hours after the declaration of the company's unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. The specific date for the Board Meeting to approve these financial results will be communicated separately. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct.